Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 02 04:00PM ET
0.7102
Dollar change
-0.0408
Percentage change
-5.43
%
Index- P/E- EPS (ttm)-0.13 Insider Own50.82% Shs Outstand35.42M Perf Week-0.11%
Market Cap24.54M Forward P/E- EPS next Y-1.12 Insider Trans-0.49% Shs Float17.43M Perf Month-17.51%
Income-4.62M PEG- EPS next Q-0.32 Inst Own5.32% Short Float0.88% Perf Quarter-26.86%
Sales45.91M P/S0.53 EPS this Y-31.58% Inst Trans-6.49% Short Ratio0.91 Perf Half Y-51.69%
Book/sh0.65 P/B1.09 EPS next Y-123.33% ROA-10.29% Short Interest0.15M Perf Year22.47%
Cash/sh0.75 P/C0.95 EPS next 5Y- ROE-19.52% 52W Range0.48 - 3.25 Perf YTD-1.77%
Dividend Est.- P/FCF- EPS past 5Y18.79% ROI-19.72% 52W High-78.15% Beta1.78
Dividend TTM- Quick Ratio3.04 Sales past 5Y25.79% Gross Margin99.71% 52W Low48.30% ATR (14)0.08
Dividend Ex-DateJun 12, 2009 Current Ratio3.04 EPS Y/Y TTM44.73% Oper. Margin-14.74% RSI (14)40.98 Volatility7.95% 10.02%
Employees44 Debt/Eq0.02 Sales Y/Y TTM7.70% Profit Margin-10.05% Recom1.67 Target Price4.33
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q99.81% Payout- Rel Volume0.47 Prev Close0.75
Sales Surprise5.29% EPS Surprise-100.00% Sales Q/Q37.10% EarningsNov 13 AMC Avg Volume168.85K Price0.71
SMA20-4.22% SMA50-19.70% SMA200-44.63% Trades Volume79,229 Change-5.43%
Date Action Analyst Rating Change Price Target Change
Oct-29-21Resumed Stifel Buy $12
Sep-15-21Initiated Cantor Fitzgerald Overweight $14
Jul-14-20Reiterated H.C. Wainwright Buy $14 → $24
Jul-10-20Resumed Stifel Buy $22 → $10
Feb-22-19Initiated SVB Leerink Outperform $16
Nov-13-24 04:01PM
08:00AM
Nov-12-24 08:00AM
Nov-06-24 10:00AM
Oct-31-24 07:00AM
08:00AM Loading…
Oct-07-24 08:00AM
Sep-17-24 11:54AM
Sep-10-24 08:00AM
Sep-04-24 08:00AM
Aug-28-24 08:00AM
Aug-08-24 05:35PM
04:01PM
Aug-06-24 08:00AM
Jul-18-24 01:57PM
Jul-02-24 08:00AM
08:00AM Loading…
Jun-12-24 08:00AM
Jun-05-24 08:00AM
Jun-04-24 08:00AM
May-29-24 08:00AM
May-14-24 08:00AM
May-09-24 10:56PM
05:35PM
04:01PM
May-07-24 08:00AM
Apr-03-24 08:00AM
Apr-01-24 10:15AM
08:00AM
Mar-25-24 09:53PM
05:10PM
04:01PM
08:00AM Loading…
Mar-22-24 08:00AM
Jan-29-24 04:07AM
Dec-21-23 09:52AM
08:00AM
Nov-20-23 11:23AM
Nov-13-23 09:00AM
Nov-08-23 04:01PM
Nov-06-23 08:00AM
Oct-24-23 12:30PM
Oct-19-23 08:00AM
Oct-16-23 08:00AM
Oct-03-23 08:00AM
Oct-02-23 08:00AM
Sep-20-23 08:00AM
Aug-30-23 08:00AM
Aug-12-23 08:05AM
Aug-09-23 05:30PM
04:01PM
Aug-02-23 04:00PM
Jun-01-23 08:00AM
May-15-23 08:00AM
May-11-23 05:25PM
04:01PM
May-03-23 06:14AM
Apr-24-23 08:00AM
Mar-23-23 04:01PM
Mar-22-23 08:00AM
Feb-17-23 08:00AM
Feb-07-23 08:00AM
Jan-13-23 08:00AM
Dec-23-22 04:01PM
Dec-16-22 08:00AM
Dec-06-22 12:17PM
07:00AM
Nov-14-22 04:01PM
08:00AM
Nov-10-22 08:00AM
Nov-08-22 08:00AM
Nov-03-22 08:00AM
Nov-02-22 08:00AM
Oct-26-22 08:00AM
Sep-27-22 08:15AM
08:04AM
07:00AM
Sep-15-22 08:00AM
Sep-07-22 05:58AM
Sep-06-22 04:00PM
Aug-31-22 08:00AM
Aug-18-22 07:48AM
Aug-15-22 04:01PM
Jul-28-22 08:00AM
Jun-14-22 02:09PM
May-17-22 08:00AM
May-12-22 04:01PM
08:00AM
May-09-22 08:00AM
Apr-25-22 08:00AM
Apr-04-22 08:00AM
Mar-29-22 10:00AM
Mar-28-22 12:00PM
Mar-24-22 08:00AM
Mar-23-22 04:01PM
01:42PM
Mar-04-22 08:00AM
Mar-01-22 08:00AM
Feb-16-22 11:22AM
07:00AM
Feb-15-22 08:00AM
Feb-09-22 08:00AM
Feb-02-22 06:46AM
Equillium, Inc. engages in the development of products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March, 2017 and is headquartered in La Jolla, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Keyes Jason AChief Financial OfficerNov 14 '24Sale0.7010,0007,00047,720Nov 15 06:23 PM
THE KEYES TRUST U/A DTD 09/10/OfficerNov 14 '24Proposed Sale0.7820,00015,608Nov 14 04:19 PM
Zedelmayer ChristineOfficerOct 28 '24Proposed Sale1.2515,00018,750Oct 31 12:19 PM
Zedelmayer ChristineSr. Vice President and COOOct 28 '24Sale1.2515,00018,750135,246Oct 30 08:59 PM
Tom PennyPrincipal Accounting OfficerOct 28 '24Sale1.252,8353,5446,533Oct 29 04:15 PM
Tom PennyPrincipal Accounting OfficerOct 25 '24Sale1.256838549,368Oct 29 04:15 PM
Keyes Jason AChief Financial OfficerSep 26 '24Sale0.8110,0008,10057,720Sep 27 07:38 PM
Tom PennyPrincipal Accounting OfficerSep 16 '24Sale0.8538,80632,98510,051Sep 17 06:14 PM
Keyes Jason AChief Financial OfficerJul 16 '24Sale0.8710,0008,70067,720Jul 18 05:52 PM